Risk factors for nonsynchronous second primary malignancy and related death in patients with differentiated thyroid carcinoma

Annals of Surgical Oncology

Volumn 18, Issue 13, 2011, Pages 3559-3565

  Lang, Brian Hung Hin ^a   Wong, Kai Pun ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CAUSE OF DEATH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SECOND CANCER; THYROID CANCER; THYROID CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; THYROID NEOPLASMS; YOUNG ADULT;

EID: 82955233589     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1777-1     Document Type: Article

References (22)

1. Cancer incidence and mortality in Hong Kong 1983-2006. Hong Kong Cancer Registry, Hong Kong. http://www3.ha.org.hk/cancereg/e-stat.asp. Accessed on 15 Jan 2010.
2. BL Sprague S Warren Andersen A Trentham-Dietz 2008 Thyroid cancer incidence and socioeconomic indicators of health care access Cancer Causes Control. 19 585 593 18240001 10.1007/s10552-008-9122-0
3. BH Lang CY Lo WF Chan KY Lam KY Wan 2007 Prognostic factors in papillary and follicular thyroid carcinoma: implications for cancer staging Ann Surg Oncol. 14 730 738 17103065 10.1245/s10434-006-9207-5 (Pubitemid 46175319)
4. ID Hay T Gonzalez-Losada MS Reinalda JA Honetschlager ML Richards GB Thompson 2010 Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008 World J Surg. 34 1192 1202 20087589 10.1007/s00268-009-0364-0
5. AP Brown J Chen YJ Hitchcock A Szabo DC Shrieve JD Tward 2008 The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer J Clin Endocrinol Metab. 93 504 515 18029468 10.1210/jc.2007-1154 1:CAS:528:DC%2BD1cXit1Sntb8%3D (Pubitemid 351240823)
6. C Rubino F de Vathaire ME Dottorini P Hall C Schvartz JE Couette, et al. 2003 Second primary malignancies in thyroid cancer patients Br J Cancer. 89 1638 1644 14583762 10.1038/sj.bjc.6601319 1:STN:280:DC%2BD3srgs1GrsA%3D%3D (Pubitemid 37464133)
7. TC Sandeep MW Strachan RM Reynolds DH Brewster G Scelo E Pukkala, et al. 2006 Second primary cancers in thyroid cancer patients: a multinational record linkage study J Clin Endocrinol Metab. 91 1819 1825 16478820 10.1210/jc.2005-2009 1:CAS:528:DC%2BD28XkslCntbo%3D
8. BH Lang CY Lo IO Wong BJ Cowling 2010 Impact of second primary malignancy on outcomes of differentiated thyroid carcinoma Surgery. 148 1191 1196 21134551 10.1016/j.surg.2010.09.022
9. CM Ronckers P McCarron E Ron 2005 Thyroid cancer and multiple primary tumors in the SEER cancer registries Int J Cancer. 117 281 288 15880372 10.1002/ijc.21064 1:CAS:528:DC%2BD2MXhtVygsrfN (Pubitemid 41377449)
10. Y Nio C Iguchi M Itakura, et al. 2009 High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders Anticancer Res. 29 1607 1610 19443373
11. S Sadetzki R Calderon-Margalit C Peretz, et al. 2003 Second primary breast and thyroid cancers Cancer Causes Control. 14 367 375 12846369 10.1023/A:1023908509928 (Pubitemid 36735107)
12. RB Verkooijen JW Smit JA Romijn MP Stokkel 2006 The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer Eur J Endocrinol. 155 801 806 17132748 10.1530/eje.1.02300 1:CAS:528:DC%2BD2sXjsVOkuw%3D%3D (Pubitemid 46040617)
13. HS Wu MT Young PH Ituarte, et al. 2000 Death from thyroid cancer of follicular cell origin J Am Coll Surg. 191 600 606 11129807 10.1016/S1072- 7515(00)00731-6 1:STN:280:DC%2BD3M%2FosFentw%3D%3D (Pubitemid 32004984)
14. CF Eustatia-Rutten EP Corssmit NR Biermasz AM Pereira JA Romijn JW Smit 2006 Survival and death causes in differentiated thyroid carcinoma J Clin Endocrinol Metab. 91 313 319 16263822 10.1210/jc.2005-1322 1:CAS:528: DC%2BD28Xms1altw%3D%3D (Pubitemid 43069155)
15. IO Wong WS Chan S Choi SV Lo GM Leung 2006 Moral hazard or realised access to care? Empirical observation in Hong Kong Health Policy. 75 251 261 16399169 10.1016/j.healthpol.2005.03.002 (Pubitemid 43042359)
16. BH Lang CY Lo WF Chan KY Lam KY Wan 2007 Staging systems for papillary thyroid carcinoma: a review and comparison Ann Surg. 30 133 138
17. TP Links KM van Tol PL Jager, et al. 2005 Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis Endocr Relat Cancer. 12 273 280 15947102 10.1677/erc.1.00892 1:STN:280: DC%2BD2M3pvF2qsQ%3D%3D (Pubitemid 40896446)
18. S Subramanian DP Goldstein L Parlea, et al. 2007 Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis Thyroid. 17 1277 1288 18020916 10.1089/thy.2007.0171
19. DS Cooper GM Doherty BR Hauger RT Kloos SL Lee SJ Mandel, et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid. 19 1167 1214 19860577 10.1089/thy.2009.0110
20. SK Pal A Hurria 2010 Impact of age, sex, and comorbidity on cancer therapy and disease progression J Clin Oncol. 28 4086 4093 20644100 10.1200/JCO.2009.27.0579
21. L Rajdev 2010 Treatment options for surgically resectable gastric cancer Curr Treat Options Oncol. 11 14 23 20358316 10.1007/s11864-010-0117-1
22. EK Wei KY Wolin GA Colditz 2010 Time course of risk factors in cancer etiology and progression J Clin Oncol. 28 4052 4057 20644083 10.1200/JCO.2009.26.9324